1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > ADHD Medication Manufacturing - Industry Market Research Report

In good health: Wider recognition and increasing health reforms will support the industry



ADHD Medication Manufacturing

The use of medication for the treatment of attention deficit disorders, such as ADHD, is growing. The recent recognition of ADHD as a condition that can also afflict adults has provided a boon to the industry, and healthcare reform has enabled more children to access behavioral health services, resulting in more patients being able to have their ADHD identified and treated. In the five years to 2021, industry revenue will continue to grow as the trends from the previous five years bolster utilization rates. However, many brand-name drugs are set to lose their patent exclusivity, which will incite more generic drug manufacturers to inundate the market with low-cost drugs, intensifying price-based competition.

This industry manufactures medications that treat people with attention deficits, such as attention deficit disorder (ADD) and attention deficit hyperactivity disorder (ADHD).

This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.



Related Reports

Brand Name Pharmaceutical Manufacturing in the US

Generic Pharmaceutical Manufacturing in the US

Drug, Cosmetic & Toiletry Wholesaling in the US

Psychologists, Social Workers & Marriage Counselors in the US

Table Of Contents

ADHD Medication Manufacturing - Industry Market Research Report

TABLE OF CONTENTS

ABOUT THIS INDUSTRY
Industry Definition
Main Activities
Similar Industries
Additional Resources

INDUSTRY AT A GLANCE

INDUSTRY PERFORMANCE
Executive Summary
Key External Drivers
Current Performance
Industry Outlook
Industry Life Cycle

PRODUCTS and MARKETS
Supply Chain
Products and Services
Demand Determinants
Major Markets
International Trade
Business Locations

COMPETITIVE LANDSCAPE
Market Share Concentration
Key Success Factors
Cost Structure Benchmarks
Basis of Competition
Barriers to Entry
Industry Globalization

MAJOR COMPANIES

OPERATING CONDITIONS
Capital Intensity
Technology and Systems
Revenue Volatility
Regulation and Policy
Industry Assistance

KEY STATISTICS
Industry Data
Annual Change
Key Ratios

JARGON and GLOSSARY



MAJOR COMPANIES

Shire Pharmaceuticals

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Lambert-Eaton Myasthenic Syndrome (LEMS) Global Clinical Trials Review, H2, 2016

Lambert-Eaton Myasthenic Syndrome (LEMS) Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by Global Data

Lambert-Eaton Myasthenic Syndrome (LEMS) Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Lambert-Eaton Myasthenic Syndrome (LEMS) Global Clinical Trials Review, H2, ...

Amyotrophic Lateral Sclerosis Global Clinical Trials Review, H2, 2016

Amyotrophic Lateral Sclerosis Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by Global Data

Amyotrophic Lateral Sclerosis Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Amyotrophic Lateral Sclerosis Global Clinical Trials Review, H2, 2016" provides an overview ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.